Font Size: a A A
Keyword [liposomal irinotecan]
Result: 1 - 2 | Page: 1 of 1
1. SHR-1316,an Anti-PD-L1 Antibody,plus Chemotherapy As The First-line Treatment For Advanced Esophageal Squamous Cell Carcinoma:a Multi-centre,phase 2 Study
2. Phase ? Study Of Liposomal Irinotecan(LY01610)in Patients With Advanced Esophageal Squamous Cell Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to